Emerge Matrix
Placental Tissue
Placental tissue, previously considered biologic waste following delivery, is a pristine newly formed extracellular matrix (ECM) to protect and support fetal development. Therefore, this tissue represents an untainted extracellular matrix…essentially a neomatrix.
Description Of Layers
Broadly, placental tissue includes an internal or fetus facing amnion and an external or maternal facing chorion. The physical and biochemical properties of the two primary membranes are subtly different owing to the position they occupy in the placenta. The amnion is a thinner yet more compact layer of extracellular matrix while the chorion is a slightly thicker but less compact matrix. Both layers are constituted of collagen fibers (predominantly Types I, Ill, IV and V), along with other ECM proteins (including laminin, fibronectin, proteoglycans and hyaluronic acid).
Safety
Donated tissues for Emerge™ products are collected from fully consented mothers undergoing full term.
c-sections. Each donor is screened according to the strict standards required by the U.S. Food and Drug Administration and the American Association of Tissue Banks. Further, Emerge™ Placental-Derived Allograft products undergo a validated terminal sterilization process to help ensure these products are safe. All donated tissue is obtained with FDA-regulated and accredited recovery organizations. Additional details of screening procedures can be found in the product package insert or Instructions for Use.
Product Overview & Usage Guide
Product Specifications
- 1. H. Niknejad, H. Peirovi, MJorjani, et al, “Properties of the Amniotic Membrane for Potential Use in Tissue Engineering”, EurCell Mater, vol. 15, pp 88-99, 2008.
- 2. A. Roy, M. Mantay, C. Brannan, and S. Griffiths, “Placental Tissues as Biomaterials in Regenerative Medicine”BioMed Research International, vol. 2022, pp. 1-26, 2022.
